Skip to content
Cyclodextrin News

Cyclodextrin News

A forum for researchers, students and applicants in the field of cyclodextrin technology

  • Home
  • Pharma applications
  • Non-pharma applications
  • CD derivatives
  • Events
  • E-ducation

Tag: soil remediation

December 3, 2020 Environmental / Non-pharma applications

Soil bioremediation by cyclodextrins. A review

Remediation of soils contaminated by organic pollutants has become an urgent necessity worldwide. A wide variety of techniques have been

Continue reading

October 22, 2019 Environmental / Non-pharma applications

Role of cyclodextrins in the extraction and bioremediation of soils co-contaminated by organic pollutants and potentially toxic elements

Pollution of soils by persistent organic pollutants and potentially toxic elements (PTEs) is currently a significant concern worldwide. In many

Continue reading

August 10, 2019 Environmental / Non-pharma applications

CD-enhanced soil remediation by ‘sugar flushing’

There are several soil remediation technologies utilizing cyclodextrins as solubilizers of organic contaminants (Gruiz et al. 2019). Soil washing/flushing with

Continue reading

February 7, 2019 Environmental / Non-pharma applications

CDs in biodegradation-based soil remediation under aerobic conditions

The non-toxic, biodegradable cyclodextrins (CDs) can solubilize poorly soluble organic contaminants such as PAHs, PCBs, chlorinated solvents, etc. via molecular

Continue reading

January 30, 2019 Environmental / Non-pharma applications

CD-enabled elektrokinetic extraction of pollutants from soil

The electrokinetic extraction process removes metals and polar organic contaminants from low-permeability soil, mud, sludge, and marine dredging by applying

Continue reading

Recent Posts

  • Bacteroides uniformis and its preferred substrate, α-cyclodextrin, enhance endurance exercise performance in mice and human males
  • Waterproof and durable luminescent textiles with HPBCD for marine rescue
  • Small anticancer drug release by light
  • Patent application on reduction of envelope viral particle number in a composition containing cyclodextrin
  • γ-Cyclodextrin/Epigallocatechin-3-gallate Inclusion Complexes as Efficient Antioxidants for Preservation of Shrimp Surimi Products

Tags

alpha-CD antiviral Biotechnology Cancer therapy Captisol Cholesterol Clinical trial conference coronavirus Covid-19 cyclodextrin polymer Dexolve drug delivery drug delivery systems FDA Food Gilead History HPBCD Nanoparticles nanotechnology Niemann Pick Disease RAMEB remdesivir SBECD Special issue Sugammadex Synthesis wastewater treatment

Follow Us

  • LinkedIn
  • Twitter
  • Facebook

Categories

  • Agriculture (13)
  • Analysis (35)
  • CD as API (199)
  • CD derivatives (251)
  • Cosmetics and toilettry (21)
  • Drug delivery (416)
  • E-ducation (54)
  • Environmental (76)
  • Events (157)
  • Food (120)
  • Gene delivery (10)
  • In Hungarian (4)
  • Life sciences (13)
  • Non-pharma applications (209)
  • Other industrial use (58)
  • Pharma applications (677)
  • Supramolecular systems (25)
  • Uncategorized (41)

Top Posts

  • Lanosterol eye drops for cataract treatment
  • Waterproof and durable luminescent textiles with HPBCD for marine rescue
  • Bacteroides uniformis and its preferred substrate, α-cyclodextrin, enhance endurance exercise performance in mice and human males
  • γ-Cyclodextrin/Epigallocatechin-3-gallate Inclusion Complexes as Efficient Antioxidants for Preservation of Shrimp Surimi Products
  • Small anticancer drug release by light
  • New book: Cyclodextrins - new Perspectives
  • Cyclodextrin Metal-Organic Framework as a Broad-Spectrum Potential Delivery Vehicle for the Gasotransmitters
  • MIT scientists filed patent for HPBCD treatment in Alzheimer's disease
  • Pilocarpine eye drops (Vuity)
  • Current Overview of Cyclodextrin-Based Nanocarriers for Enhanced Antifungal Delivery

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 521 other subscribers
 

Loading Comments...